Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD

Rank in Stocks #27419
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Share Price
$1.18
Last synced: 2026-11-13
Market Cap
$14.93M
Change (1 day)
1.72%
Change (1 year)
-70.72%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Tvardi Therapeutics, Inc. (TVRD)

Category

Healthcare
Operating Margin for Tvardi Therapeutics, Inc. (TVRD)
Operating Margin as of November 2026 TTM: 0.00%
According to Tvardi Therapeutics, Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Tvardi Therapeutics, Inc. from 2020 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% -100.00%
2024 -781.57% 34.89%
2023 -579.43% 177.13%
2022 -209.08% -45.95%
2021 -386.85% -9,795.49%
2020 3.99% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -
US
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Tvardi Therapeutics, Inc.'s operating margin

What was Tvardi Therapeutics, Inc.'s operating margin in 2025?

In 2025, Tvardi Therapeutics, Inc.'s operating margin was 0.00%, compared with -781.57% in 2024.

How has Tvardi Therapeutics, Inc.'s operating margin changed since 2020?

From 2020 to 2025, Tvardi Therapeutics, Inc.'s operating margin was highest in 2020 (3.99%) and lowest in 2024 (-781.57%).

How does Tvardi Therapeutics, Inc.'s operating margin compare with similar companies?

Tvardi Therapeutics, Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.